Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Imperial Brands PLC Add to portfolio

LON100:IMB, Jul 18, 08:49 UTC

Latest LON100:IMB News

Filter your feed

Apply Filter

Saturday, July 07


Social Chatter

Imperial Brands PLC (LON100:IMB) social chatter is higher than usual

IMB
Snoop Dogg’s VC and Imperial Tobacco Investing in Cannabis Biotech. https://t.co/ptzbXCz3vB https://t.co/gLTuPH3sSo

Thursday, July 05


News

Imperial Takes on Juul as Big Tobacco Faces Upstart Rival

IMB

Company is launching nicotine salt pods in U.S. and U.K. Juul’s rapid growth has sparked selloff of tobacco stocks. Imperial Brands Plc is launching a vaping product to compete with Juul Labs Inc., as Chief Executive Officer Alison Cooper steps up efforts to reassure investors that smoking alternatives are an opportunity rather than a threat. Juul gives vapers a hit comparable to that of a cigarette because it contains benzoic acid, which makes it easier to deliver nicotine at a lower temperature without being harsh to the throat. The U.S. is the world’s biggest e-cigarette market -- and the only one in which Imperial is profitable. But Juul’s rise caused Imperial’s market share to fall by more than half to 8 percent since last year, according to Wells Fargo.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Friday, June 29


Social Chatter

Imperial Brands PLC (LON100:IMB) social chatter is higher than usual

IMB
Snoop Dogg’s VC and Imperial Tobacco Investing in Cannabis Biotech https://t.co/eyKE6MZRAN
Social Chatter

Thursday, June 28


News

Cigarette maker Imperial betting on medical pot

IMB

Marijuana plants grow at the PharmaCielo facility in Rionegro, Colombia.Photo: Eduardo Leal/Bloomberg News. The investment marks the latest move by the world’s biggest tobacco and alcohol companies to explore opportunities from the widening acceptance of the drug.The... LONDON— Imperial Brands PLC, the owner of Winston and Maverick cigarettes, bought a minority stake in Oxford Cannabinoid Technologies, a U.K.-based startup focused on research into medical uses of cannabis. The London-based company, formerly known as Imperial Tobacco, is contributing about £10 million ($13.1 million) in a funding round for the firm, according to a person familiar with the deal. Last year, Constellation Brands Inc., the U.S. distributor of Modelo and Corona, took a stake in a Canadian marijuana company, and said it plans to work with the grower, Canopy Growth Corp. , to develop and market cannabis-infused beverages.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Imperial Brands, Snoop Dogg VC Firm Invest In Patrick Stewart-Backed Marijuana Biotech

IMB BATS

Snoop Dogg, Sir Patrick Stewart and a large British tobacco company: all vaguely in the same news story, thanks to an investment deal announced late Wednesday that an analyst called Big Tobacco's "most significant" attempt yet to gain exposure to the marijuana industry.X. Imperial Brands Ventures, a subsidiary of U.K. tobacco giant Imperial Brands (IMBBY), and Snoop Dogg's venture capital firm, Casa Verde Capital, said they are investing in Oxford Cannabinoid Technologies, a British medical marijuana research firm backed by Stewart of "Star Trek" and "X-Men" fame. The decision by Imperial, whose cigarette brands include Winston and Kool, comes roughly a year after the company appointed the chairman of a medical cannabis company to its board. The spokesman for Imperial told IBD this year that the company appointed Langelier largely due to his three-decade stint at Philip Morris International. However, the spokesman added that Langelier's cannabis background was not "irrelevant," either. Some analysts believe that the quickly growing — and destigmatizing — marijuana industry presents more of an opportunity for tobacco firms than alcohol.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Tobacco giant Imperial Brands invests in medical cannabis

IMB

Share this with EmailShare this with FacebookShare this with TwitterShare this with Whatsapp. Tobacco firm Imperial Brands is investing in UK biotech company Oxford Cannabinoid Technologies (OCT). A company subsidiary, Imperial Brands Ventures, is taking a stake in the UK firm, but its size is unknown. Imperial now sees itself as "a dynamic fast-moving consumer goods company borne out of a strong tobacco heritage".

Read Full Details

Story Sources

bbc.com bbc.co.uk
Topics:
  • Business
  • Health
  • Financial
News

Imperial Brands invests in cannabis-based medical research

IMB

(Reuters) - Tobacco company Imperial Brands is investing in Oxford Cannabinoid Technologies, to help the British biotech company research how marijuana can be used in medicine. The maker of Gauloises and Winston cigarettes said on Thursday that its subsidiary, Imperial Brands Ventures, was taking an equity stake in the British company. The investment comes a year after Imperial named an expert in medicinal cannabis to its board of directors and shows how big tobacco companies are trying to diversify away from the shrinking tobacco market. It also comes days after the U.S. Food and Drug Administration approved the use of a cannabis-based drug for the first time, a move seen as opening floodgates for more research into the medicinal properties of cannabis.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Imperial Brands invests in cannabis-based medical research

IMB TRI

LONDON, June 28 (Reuters) - Tobacco company Imperial Brands (LSE: IMB.L - news) is investing in Oxford Cannabinoid Technologies, to help the British biotech company research how marijuana can be used in medicine. The maker of Gauloises and Winston cigarettes said on Thursday that its subsidiary, Imperial Brands Ventures, was taking an equity stake in the British company. The investment comes a year after Imperial named an expert in medicinal cannabis to its board of directors and shows how big tobacco companies are trying to diversify away from the shrinking tobacco market. It also comes days after the U.S. Food and Drug Administration approved the use of a cannabis-based drug for the first time, a move seen as opening floodgates for more research into the medicinal properties of cannabis.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Tuesday, June 26


News

Imperial Brands PLC (IMT) Receives Average Recommendation of “Buy” from Brokerages

IMB

Shares of Imperial Brands PLC (LON:IMT) have received an average recommendation of “Buy” from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is GBX 3,143 ($42.17). Several analysts recently weighed in on IMT shares. Societe Generale set a GBX 3,000 ($40.25) price target on shares of Imperial Brands and gave the company a “buy” rating in a report on Monday, April 23rd.

Read Full Details

Topics:
  • Business
  • Financial